A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor
Clinical trial NCT02079532 · COMPLETED
Trial details
- NCT number
- NCT02079532
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2010-11-01
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.